Decline of RSV-specific antibodies during the COVID-19 pandemic-Reference-Cited by-同舟云学术

Decline of RSV-specific antibodies during the COVID-19 pandemic

Published:2023-01 Issue:1 Volume:23 Page:23-25
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

den Hartog Gerco,van Kasteren Puck B,Schepp Rutger M,Teirlinck Anne C,van der Klis Fiona R M,van Binnendijk Robert S

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference8 articles.

1. Epidemiology of respiratory syncytial virus in children younger than 5 years in England during the COVID-19 pandemic, measured by laboratory, clinical, and syndromic surveillance: a retrospective observational study;Bardsley;Lancet Infect Dis,2022

2. Impact of COVID-19 social distancing on viral infection in France: a delayed outbreak of RSV;Delestrain;Pediatr Pulmonol,2021

3. Off-season RSV epidemics in Australia after easing of COVID-19 restrictions;Eden;Nat Commun,2022

4. Quantifying the RSV immunity debt following COVID-19: a public health matter;Billard;Lancet Infect Dis,2022

5. Waning Immunity against respiratory syncytial virus during the COVID-19 pandemic;Reicherz;J Infect Dis,2022

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Birth characteristics as predictors of respiratory syncytial virus hospitalisation in newborns to optimise immunisation schedule;Acta Paediatrica;2024-01-24

2. Epidemiology of Bronchiolitis and Respiratory Syncytial Virus and Analysis of Length of Stay from 2015 to 2022: Retrospective Observational Study of Hospital Discharge Records from an Italian Southern Province before and during the COVID-19 Pandemic;Diseases;2024-01-05

3. Exploring immunity debt: Dynamic alterations in RSV antibody levels in children under 5 years during the COVID-19 pandemic;Journal of Infection;2024-01

4. Expert consensus on the diagnosis, treatment, and prevention of respiratory syncytial virus infections in children;World Journal of Pediatrics;2023-12-08

5. Effect of Palivizumab Prophylaxis on Respiratory Syncytial Virus Infection in Very Preterm Infants in the First Year of Life in The Netherlands;Vaccines;2023-12-02